[TaiGen] Announcement regarding the expiration of the term of the 5th Compensation and Nomination Committee members
Key facts
- [TaiGen] Announcement regarding the expiration of the term of the 5th Compensation and Nomination Committee members
- TaiGen Biotechnology announced that, due to the expiration of the Board of Directors' term, the terms of the 5th Compensation and Nomination Committee members (Chen Huei-You, Kuo Cheng-Hung, Liu Heng-Yi) have expired. Successors have not yet been appointed and will be announced after the next board meeting.
- Source: PR Times
- Date: June 5, 2026
Direct answer
TaiGen Biotechnology announced that, due to the expiration of the Board of Directors' term, the terms of the 5th Compensation and Nomination Committee members (Chen Huei-You, Kuo Cheng-Hung, Liu Heng-Yi) have expired. Successors have not yet been appointed and will be announced after the next board meeting.
- Citation
- [TaiGen] Announcement regarding the expiration of the term of the 5th Compensation and Nomination Committee members (June 5, 2026), PR Times
- Source
- PR Times
- Date
- June 5, 2026
TaiGen Biotechnology announced that, due to the expiration of the Board of Directors' term, the terms of the 5th Compensation and Nomination Committee members (Chen Huei-You, Kuo Cheng-Hung, Liu Heng-Yi) have expired. Successors have not yet been appointed and will be announced after the next board meeting.
📋 Article Processing Timeline
- 📰 Published: June 5, 2026 at 09:00
- 🔍 Collected: June 6, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: June 7, 2026 at 05:07 (21h 7m after Collected)
1. Date of change: 2026/06/05
2. Name of functional committee: Compensation and Nomination Committee
3. Name of former members:
(1) Independent Director: Chen Huei-You
(2) Independent Director: Kuo Cheng-Hung
(3) Independent Director: Liu Heng-Yi
4. Background of former members:
(1) Chen Huei-You: Chairman of the Life Insurance Association of the R.O.C.
(2) Kuo Cheng-Hung: Former Chairman of Deloitte Taiwan (Deloitte & Touche)
(3) Liu Heng-Yi: Associate Professor, International Business Program, College of Management, Yuan Ze University
5. Name of new members: Not yet appointed
6. Background of new members: Not yet appointed
7. Type of change: Term expiration
8. Reason for change: The term of the Compensation and Nomination Committee is aligned with the term of the Board of Directors, which has expired.
9. Original term: 2023/06/26 ~ 2026/06/11
10. Effective date for new members: N/A
11. Other information: The 6th Compensation and Nomination Committee will be announced separately following appointments at the upcoming board meeting.
2. Name of functional committee: Compensation and Nomination Committee
3. Name of former members:
(1) Independent Director: Chen Huei-You
(2) Independent Director: Kuo Cheng-Hung
(3) Independent Director: Liu Heng-Yi
4. Background of former members:
(1) Chen Huei-You: Chairman of the Life Insurance Association of the R.O.C.
(2) Kuo Cheng-Hung: Former Chairman of Deloitte Taiwan (Deloitte & Touche)
(3) Liu Heng-Yi: Associate Professor, International Business Program, College of Management, Yuan Ze University
5. Name of new members: Not yet appointed
6. Background of new members: Not yet appointed
7. Type of change: Term expiration
8. Reason for change: The term of the Compensation and Nomination Committee is aligned with the term of the Board of Directors, which has expired.
9. Original term: 2023/06/26 ~ 2026/06/11
10. Effective date for new members: N/A
11. Other information: The 6th Compensation and Nomination Committee will be announced separately following appointments at the upcoming board meeting.
FAQ
What does this announcement mean?
It indicates that the members of TaiGen Biotechnology's compensation and nomination committee have stepped down due to the expiration of their terms.
Why are the committee members changing?
Because their terms are synchronized with the term of the Board of Directors, which has expired.
When will new members be appointed?
They will be appointed during the next board meeting and announced subsequently.